Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 1
1965 2
1966 1
1967 3
1968 1
1970 2
1971 2
1972 3
1973 3
1974 1
1975 3
1976 1
1977 1
1978 4
1979 3
1980 1
1981 5
1982 4
1983 3
1984 2
1986 3
1987 2
1988 1
1989 1
1990 3
1991 1
1992 3
1993 1
1995 1
1997 3
1998 1
1999 2
2001 2
2003 3
2004 1
2006 1
2008 3
2009 1
2011 3
2012 5
2013 3
2014 4
2015 4
2016 6
2017 2
2018 4
2019 3
2020 4
2021 1
2023 4
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Gandhi L, Rodríguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Hui R, Garon EB, Boyer M, Rubio-Viqueira B, Novello S, Kurata T, Gray JE, Vida J, Wei Z, Yang J, Raftopoulos H, Pietanza MC, Garassino MC; KEYNOTE-189 Investigators. Gandhi L, et al. N Engl J Med. 2018 May 31;378(22):2078-2092. doi: 10.1056/NEJMoa1801005. Epub 2018 Apr 16. N Engl J Med. 2018. PMID: 29658856 Free article. Clinical Trial.
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
Wu YL, Tsuboi M, He J, John T, Grohe C, Majem M, Goldman JW, Laktionov K, Kim SW, Kato T, Vu HV, Lu S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Zeng L, Hodge R, Atasoy A, Rukazenkov Y, Herbst RS; ADAURA Investigators. Wu YL, et al. N Engl J Med. 2020 Oct 29;383(18):1711-1723. doi: 10.1056/NEJMoa2027071. Epub 2020 Sep 19. N Engl J Med. 2020. PMID: 32955177 Clinical Trial.
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators. Tsuboi M, et al. N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272535 Clinical Trial.
Silicon-containing analogs of camptothecin as anticancer agents.
Lazareva NF, Baryshok VP, Lazarev IM. Lazareva NF, et al. Among authors: lazarev im. Arch Pharm (Weinheim). 2018 Jan;351(1). doi: 10.1002/ardp.201700297. Epub 2017 Dec 14. Arch Pharm (Weinheim). 2018. PMID: 29239010 Review.
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study.
Peled N, Roisman LC, Levison E, Dudnik J, Chernomordikov E, Heching N, Dudnik E, Keren-Rosenberg S, Nechushtan H, Salhab A, Hershkovitz D, Tsuriel S, Hannes V, Rotem O, Lazarev I, Lichtenberg R, Granot IS, Krayim B, Shalata W, Levin D, Krutman Y, Allen AM, Blumenfeld P, Lavrenkov K, Kian W. Peled N, et al. Among authors: lazarev i. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):105-114. doi: 10.1016/j.ijrobp.2023.03.042. Epub 2023 Mar 15. Int J Radiat Oncol Biol Phys. 2023. PMID: 36925073 Clinical Trial.
Relevance of the Measles Virus Expression in Cancer - an Update.
Benharroch D, Ariad S, Tadmor N, Nalbandyan K, Lazarev I. Benharroch D, et al. Among authors: lazarev i. Pathol Oncol Res. 2016 Oct;22(4):661-6. doi: 10.1007/s12253-016-0080-7. Epub 2016 Jun 10. Pathol Oncol Res. 2016. PMID: 27287391 Free article. Review.
Stage I Breast Cancer in the Modern Era: A Retrospective Cohort Study of 328 Patients Diagnosed from 2002 to 2006 with a 14-Year Median Follow-Up.
Hadar M, Friger M, Ariad S, Koretz M, Delgado B, Tokar M, Bayme M, Agassi R, Rosenthal M, Dyomin V, Belochitski O, Amir N, Libson S, Meirovitz A, Lazarev I, Abu-Ghanem S, Geffen DB. Hadar M, et al. Among authors: lazarev i. Oncology. 2024;102(8):663-675. doi: 10.1159/000536119. Epub 2024 Jan 5. Oncology. 2024. PMID: 38185110 Free article.
Adjuvant aromatase inhibitor therapy in patients with stage I breast cancer at a regional oncology center in Israel: implementation of a 'switching' policy in postmenopausal patients after initial tamoxifen.
Geffen DB, Tokar M, Abu-Ghanem S, Braunstein R, Koretz M, Amir N, Delgado B, Sion-Vardi N, Ariad S, Lazarev I. Geffen DB, et al. Among authors: lazarev i. Oncology. 2013;85(3):145-52. doi: 10.1159/000353978. Epub 2013 Aug 28. Oncology. 2013. PMID: 23988814
122 results